WallStSmart

Cognex Corporation (CGNX)vsCoherent Inc (COHR)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Coherent Inc generates 533% more annual revenue ($6.29B vs $994.36M). CGNX leads profitability with a 11.5% profit margin vs 4.7%. COHR appears more attractively valued with a PEG of 0.92. COHR earns a higher WallStSmart Score of 52/100 (C-).

CGNX

Hold

45

out of 100

Grade: D

Growth: 5.3Profit: 5.5Value: 2.0Quality: 9.0
Piotroski: 5/9Altman Z: 3.05

COHR

Buy

52

out of 100

Grade: C-

Growth: 7.3Profit: 4.5Value: 4.7Quality: 6.3
Piotroski: 5/9Altman Z: 1.53
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CGNXSignificantly Overvalued (-77.7%)

Margin of Safety

-77.7%

Fair Value

$24.21

Current Price

$51.61

$27.40 premium

UndervaluedFair: $24.21Overvalued
COHRSignificantly Overvalued (-373.2%)

Margin of Safety

-373.2%

Fair Value

$47.27

Current Price

$272.04

$224.77 premium

UndervaluedFair: $47.27Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CGNX2 strengths · Avg: 10.0/10
Debt/EquityHealth
0.0510/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
3.0510/10

Safe zone — low bankruptcy risk

COHR4 strengths · Avg: 8.8/10
EPS GrowthGrowth
73.0%10/10

Earnings expanding 73.0% YoY

Market CapQuality
$51.06B9/10

Large-cap with strong market position

PEG RatioValuation
0.928/10

Growing faster than its price suggests

Revenue GrowthGrowth
17.5%8/10

17.5% revenue growth

Areas to Watch

CGNX3 concerns · Avg: 2.3/10
Return on EquityProfitability
7.6%3/10

ROE of 7.6% — below average capital efficiency

PEG RatioValuation
2.712/10

Expensive relative to growth rate

P/E RatioValuation
75.0x2/10

Premium valuation, high expectations priced in

COHR4 concerns · Avg: 3.0/10
Altman Z-ScoreHealth
1.534/10

Distress zone — elevated risk

Return on EquityProfitability
3.2%3/10

ROE of 3.2% — below average capital efficiency

Profit MarginProfitability
4.7%3/10

4.7% margin — thin

P/E RatioValuation
269.6x2/10

Premium valuation, high expectations priced in

Comparative Analysis Report

WallStSmart Research

Bull Case : CGNX

The strongest argument for CGNX centers on Debt/Equity, Altman Z-Score.

Bull Case : COHR

The strongest argument for COHR centers on EPS Growth, Market Cap, PEG Ratio. Revenue growth of 17.5% demonstrates continued momentum. PEG of 0.92 suggests the stock is reasonably priced for its growth.

Bear Case : CGNX

The primary concerns for CGNX are Return on Equity, PEG Ratio, P/E Ratio. A P/E of 75.0x leaves little room for execution misses.

Bear Case : COHR

The primary concerns for COHR are Altman Z-Score, Return on Equity, Profit Margin. A P/E of 269.6x leaves little room for execution misses. Thin 4.7% margins leave little buffer for downturns.

Key Dynamics to Monitor

CGNX profiles as a value stock while COHR is a growth play — different risk/reward profiles.

COHR carries more volatility with a beta of 1.91 — expect wider price swings.

COHR is growing revenue faster at 17.5% — sustainability is the question.

CGNX generates stronger free cash flow (72M), providing more financial flexibility.

Bottom Line

COHR scores higher overall (52/100 vs 45/100) and 17.5% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Cognex Corporation

TECHNOLOGY · SCIENTIFIC & TECHNICAL INSTRUMENTS · USA

Cognex Corporation offers machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks globally. The company is headquartered in Natick, Massachusetts.

Visit Website →

Coherent Inc

TECHNOLOGY · SCIENTIFIC & TECHNICAL INSTRUMENTS · USA

Coherent, Inc. provides lasers, laser-based technologies, and laser-based system solutions for a variety of scientific, commercial, and industrial research applications. The company is headquartered in Santa Clara, California.

Want to dig deeper into these stocks?